Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: ERAS) | Delayed: 14.52 -0.1 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.62 | 52 Week High | $ | |||
| Open | $14.82 | 52 Week Low | $ | |||
| Day High | $15.05 | P/E | N/A | |||
| Day Low | $14.42 | EPS | $ | |||
| Volume | 1,917,703 | |||||
